Detalhe da pesquisa
1.
Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.
J Clin Microbiol
; 59(7): e0083721, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903166
2.
Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort.
BMC Infect Dis
; 20(1): 172, 2020 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087680
3.
Association between serotonin transporter gene polymorphisms and increased suicidal risk among HIV positive patients in Uganda.
BMC Genet
; 18(1): 71, 2017 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743254
4.
Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners.
J Virol
; 87(16): 9053-63, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23760253
5.
The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies.
Front Immunol
; 15: 1325387, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469296
6.
Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations.
Front Immunol
; 15: 1348905, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357547
7.
An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2.
Bio Protoc
; 13(24): e4905, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156036
8.
Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.
Front Immunol
; 14: 1113194, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999017
9.
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy.
Front Immunol
; 14: 1183983, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205095
10.
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Hum Vaccin Immunother
; 19(2): 2240690, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553178
11.
Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals.
Front Immunol
; 14: 1255676, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098482
12.
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.
Front Immunol
; 14: 1152522, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37006272
13.
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.
Front Immunol
; 14: 1148877, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37153598
14.
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Int J Infect Dis
; 136: 49-56, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683720
15.
Bacterial microbiome and host inflammatory gene expression in foreskin tissue.
Heliyon
; 9(11): e22145, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053902
16.
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.
AIDS
; 37(11): 1651-1659, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289572
17.
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.
EBioMedicine
; 93: 104648, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327677
18.
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
PLoS One
; 17(11): e0275927, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327320
19.
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.
Front Immunol
; 13: 965214, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967369
20.
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.
Front Immunol
; 13: 1009978, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479111